Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
RCEL

Market Cap: $193.03M

AI

Avita Medical Inc.

RCEL

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin81.56%

EBITDA Margin-47.30%

EBIT Margin-49.82%

Pre-tax Margin-56.94%

Net Profit Margin-56.96%

Earnings Yield-18.03%

Valuation Multiples

Price / Book-8.58

Price / Sales2.55

Price / Earnings-0.22

PEG0.00

Forward PEG0.00

EV / Sales2.46

EV / EBITDA-5.19

EV / Operating Cash Flow-5.41

EV / Free Cash Flow-5.51

Price / Free Cash Flow-5.73

Price / Operating Cash Flow-6.97

Cash Flow & Capital

Free Cash Flow / Share-$1.1

Operating Cash Flow / Share-$1.12

Free Cash Flow Yield-17.45%

Capex / Revenue0.81%

Capex / Operating Cash Flow-1.78%

Capex / Depreciation0.22

Stock Compensation / Revenue11.03%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio0.41

Quick Ratio0.34

Cash Ratio0.13

Debt / Assets0.04

Debt / Capital-0.07

Debt / Equity-0.07

Long-Term Debt / Capital-0.07

Debt / Market Cap0.94%

Net Debt / EBITDA0.20

Solvency Ratio-0.54

Financial Leverage-1.72

Efficiency & Working Capital

Asset Turnover1.58

Fixed Asset Turnover7.32

Inventory Turnover2.64

Receivables Turnover7.67

Payables Turnover0.00

Days Sales Outstanding47.62

Days Inventory Outstanding138.33

Days Payables Outstanding0

Operating Cycle185.95

Cash Conversion Cycle185.95

Working Capital Turnover-2.01

Returns & Quality

Return on Equity2.32%

Return on Assets-90.17%

Return on Invested Capital1.68%

ROCE1.68%

Return on Tangible Assets-1.01%

Operating Return on Assets-70.92%

Income Quality0.64

Tax Burden1.00

Interest Burden1.14

Balance Sheet & Intrinsic Metrics

Enterprise Value$185.71M

Invested Capital$-24.74M

Working Capital$-40.32M

Tangible Asset Value$-33.09M

Net Current Asset Value$-47.22M

Graham Net-Net-$1.77

Book Value / Share-$0.91

Tangible Book Value / Share-$1.08

Cash / Share$0.36

Financial Health Scores

Piotroski Score3

Altman Z-Score-13.20

Revenue$75.63M

EBIT$-37.68M

Market Cap$167.9M

Working Capital$-40.32M

Retained Earnings$-426.68M

Total Assets$47.78M

Total Liabilities$75.62M